- 12 Apr 2020
Items and actions
- The Advisory Group discussed current gaps in knowledge to be addressed, including data on transmission in hospitals and the impact of the pandemic on non-covid related presentation and treatment.
- The Advisory Group discussed the potential for unintended consequences of measures taken to counter the spread of Covid-19, noting the need for additional evidence in a number of areas. Group members discussed current research underway to better understand the potential health impact of Non Pharmaceutical Interventions on a range of health outcomes.
- The Group agreed to feed into UK-wide discussions, including consideration of exit strategies, and to consider how the research gaps identified could be addressed.
- Updates were provided to the group on ongoing work on testing capacity, the newly-established data taskforce, and ongoing refinements to modelling.